MTCH2 and colorectal carcinoma: To investigate the relationship between MTCH2 expression and clinicopathological characteristics of CRC, we first divided the 172 CRC patients into MTCH2‐high (87 cases) and MTCH2‐low (85 cases) expression groups based on IHC scores (Table1).